Search Results 1321-1330 of 20102 for Hepatitis C

1. Study Of ABBV-383 Assessing Adverse Events And Clinical Activity With Subcutaneous (SC) Injection In Adult Participants With Relapsed Or Refractory Multiple Myeloma

   Subject has evidence of active hepatitis C infection based on screening blood testing;. Subject may not be seropositive for hepatitis C, except in the ...

2. A Global Study To Assess The Drug Dynamics, Efficacy, And Safety Of GZ/SAR402671 In Parkinson's Disease Patients Carrying A Glucocerebrosidase (GBA) Gene Mutation - Mayo Clinic

   ... hepatitis B immunization are eligible if other criteria are met (ie, negative tests for : HBsAg, hepatitis B core antibody [HBcAb],and hepatitis C [HCVAb].

3. Maraviroc (oral route) - Side effects & dosage - Mayo Clinic

   Make sure you tell your doctor if you have any other medical problems, especially: Heart disease or; Liver problems (eg, hepatitis B or C), history of or ...

4. A Study of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) - Mayo Clinic

   Hepatitis B defined as presence of hepatitis B surface antigen (HBsAg);; Hepatitis C defined as presence of HCV RNA 13. Known history of HIV. Evidence of ...

5. A Study Of The Safety And Effectiveness Of RoActemra/Actemra (Tocilizumab) For Patients With Giant Cell Arteritis - Mayo Clinic

   Positive for hepatitis B or hepatitis C infection. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

6. Phase 2 Study Of TAK-341 For Multiple System Atrophy - Mayo Clinic

   ... hepatitis C infection, or known history of HIV infection: Note: Subjects with positive hepatitis C virus (HCV) serology results may be enrolled if results ...

7. Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis c virus [HCV] ribonucleic acid [RNA] ...

8. A Study Of Pirtobrutinib In Participants With Immune Thrombocytopenia - Mayo Clinic

   * Have hepatitis C virus (HCV) defined as positive for anti-HCV antibodies and PCR positive for HCV ribonucleic acid (RNA). Note: Other protocol defined ...

9. A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) - Mayo Clinic

   ... hepatitis B virus surface antigen, or hepatitis C virus. - Previous participation in a BLU-5937 trial. Note: Other protocol defined Inclusion/Exclusion ...

10. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    Participation eligibility · Presence of hepatitis B surface antigen (HBsAg) or anti-hepatitis B core antibody (anti-HBc). · Presence of hepatitis C virus (HCV) ...